| |
| |
|
| Insider
Information: |
Valenzano Ken |
| Relationship: |
SVP, Pharmacology & Bi... |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
27,687 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$293,759 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
27,687 |
|
|
| Total
Value |
$293,759 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
SVP, Pharmacology & Bi... |
2015-07-13 |
27,687 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
SVP, Pharmacology & Biology |
• – – |
2015-07-13 |
4 |
AS |
$15.00 |
$225,000 |
D/D |
(15,000) |
27,687 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Pharmacology & Biology |
• – – |
2015-07-13 |
4 |
OE |
$15.00 |
$225,000 |
D/D |
15,000 |
30,687 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Pharmacology & Biology |
• – – |
2015-06-22 |
4 |
AS |
$13.85 |
$284,013 |
D/D |
(20,500) |
27,687 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Pharmacology & Biology |
• – – |
2015-06-22 |
4 |
OE |
$13.85 |
$284,013 |
D/D |
20,500 |
48,187 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Pharmacology & Biology |
• – – |
2015-05-11 |
4 |
AS |
$10.84 |
$141,010 |
D/D |
(13,000) |
2,687 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Pharmacology & Biology |
• – – |
2015-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Pharmacology & Biology |
• – – |
2015-05-08 |
4 |
D |
$10.80 |
$100,580 |
D/D |
(9,313) |
15,687 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & Biology |
• – – |
2015-04-15 |
4 |
AS |
$12.50 |
$62,500 |
D/D |
(5,000) |
50,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & Biology |
• – – |
2015-04-15 |
4 |
OE |
$12.50 |
$62,500 |
D/D |
5,000 |
55,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & Biology |
• – – |
2015-03-20 |
4 |
AS |
$11.68 |
$91,239 |
D/D |
(7,751) |
50,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & Biology |
• – – |
2015-03-20 |
4 |
OE |
$11.68 |
$70,555 |
D/D |
6,043 |
57,751 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & Biology |
• – – |
2015-03-20 |
4 |
AS |
$11.53 |
$150,500 |
D/D |
(13,050) |
50,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & Biology |
• – – |
2015-03-20 |
4 |
OE |
$11.53 |
$150,500 |
D/D |
13,050 |
63,050 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & Biology |
• – – |
2014-11-25 |
4 |
AS |
$8.00 |
$200,000 |
D/D |
(25,000) |
50,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & Biology |
• – – |
2014-11-25 |
4 |
AB |
$8.00 |
$200,000 |
D/D |
25,000 |
75,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & Biology |
• – – |
2014-08-25 |
4 |
AS |
$6.00 |
$74,700 |
D/D |
(12,450) |
51,708 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & Biology |
• – – |
2014-08-25 |
4 |
AB |
$6.00 |
$74,700 |
D/D |
12,450 |
64,158 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & Biology |
• – – |
2014-08-20 |
4 |
AB |
$5.40 |
$37,800 |
D/D |
7,000 |
58,708 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & Biology |
• – – |
2014-08-20 |
4 |
AS |
$5.40 |
$37,800 |
D/D |
(7,000) |
51,708 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & Biology |
• – – |
2014-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
51,708 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & Biology |
• – – |
2011-05-24 |
4 |
S |
$7.50 |
$16,875 |
D/D |
(2,250) |
1,708 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & Biology |
• – – |
2011-05-24 |
4 |
OE |
$0.64 |
$1,436 |
D/D |
2,250 |
3,958 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Pharmacology & BiologyOffi |
• – – |
2010-05-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,708 |
|
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
